The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Serotonin and epilepsy
Abstract
In recent years, there has been increasing evidence that serotonergic neurotransmission modulates a wide variety of experimentally induced seizures. Generally, agents that elevate extracellular serotonin (5‐HT) levels, such as 5‐hydroxytryptophan and serotonin reuptake blockers, inhibit both focal and generalized seizures, although exceptions have been described, too. Conversely, depletion of brain 5‐HT lowers the threshold to audiogenically, chemically and electrically evoked convulsions. Furthermore, it has been shown that several anti‐epileptic drugs increase endogenous extracellular 5‐HT concentration. 5‐HT receptors are expressed in almost all networks involved in epilepsies. Currently, the role of at least 5‐HT 1A, 5‐HT 2C, 5‐HT 3 and 5‐HT 7 receptor subtypes in epileptogenesis and/or propagation has been described. Mutant mice lacking 5‐HT 1A or 5‐HT 2C receptors show increased seizure activity and/or lower threshold. In general, hyperpolarization of glutamatergic neurons by 5‐HT 1A receptors and depolarization of GABAergic neurons by 5‐HT 2C receptors as well as antagonists of 5‐HT 3 and 5‐HT 7 receptors decrease the excitability in most, but not all, networks involved in epilepsies. Imaging data and analysis of resected tissue of epileptic patients, and studies in animal models all provide evidence that endogenous 5‐HT, the activity of its receptors, and pharmaceuticals with serotonin agonist and/or antagonist properties play a significant role in the pathogenesis of epilepsies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
A permanent change in brain function resulting from daily electrical stimulation
Goddard, G. V., McIntyre, D. C., & Leech, C. K. (1969) · Experimental Neurology · doi:10.1016/0014-4886(69)90128-9 · Cited by 3,052
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,003
Handbook of experimental pharmacology
(1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90023-5 · Cited by 1,417
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., & Julius, D. (1995) · Nature · doi:10.1038/374542a0 · Cited by 1,274
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., & Saxena, P. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90207-8 · Cited by 1,258
8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site
Middlemiss, D. N., & Fozard, J. R. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90230-3 · Cited by 861
Kindling and status epilepticus models of epilepsy: rewiring the brain
Morimoto, K., Fahnestock, M., & Racine, R. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.009 · Cited by 838
Löscher, W., & Schmidt, D. (1988) · Epilepsy Research · doi:10.1016/0920-1211(88)90054-x · Cited by 806
Molecular biology of 5-HT receptors
Boess, F. G., & Martin, I. L. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90059-0 · Cited by 677
Pet imaging of serotonin 1A receptor binding in depression
Drevets, W. C., Frank, E., Price, J. C., Kupfer, D. J., Holt, D., Greer, P. J., Huang, Y., Gautier, C., & Mathis, C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00189-4 · Cited by 666 · cited 1×
“In depressed patients, Drevets et al. (1999) found consistent widespread reduction in 5-HT1A receptor binding, with 2006 The Authors Journal Compilation 2006 International Society for Neurochemistry, J. Neurochem.”
BackgroundCellular and molecular basis of epilepsy
McNamara, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-06-03413.1994 · Cited by 649
Pape, H.-C., & McCormick, D. A. (1989) · Nature · doi:10.1038/340715a0 · Cited by 429
The concept of selectivity in 5-HT receptor research
Van Wijngaarden, I., Tulp, M. T. M., & Soudijn, W. (1990) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(90)90190-9 · Cited by 421
Destexhe, A., Bal, T., McCormick, D. A., & Sejnowski, T. J. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.3.2049 · Cited by 416
Basic mechanisms of generalized absence seizures
Snead, O. C. (1995) · Annals of Neurology · doi:10.1002/ana.410370204 · Cited by 411
Sarnyai, Z., Sibille, E. L., Pavlides, C., Fenster, R. J., McEwen, B. S., & Tóth, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14731 · Cited by 396
A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats
Kharatishvili, I., Nissinen, J. P., McIntosh, T. K., & Pitkänen, A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.012 · Cited by 368
Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain
Hoyer, D., & Middlemiss, D. N. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90159-4 · Cited by 349
Mamounas, L. A., Altar, C. A., Blue, M. E., Kaplan, D. R., Tessarollo, L., & Lyons, W. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00771.2000 · Cited by 344
Serotonin and Hippocampal Neurogenesis
Gould, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00045-7 · Cited by 328
Inhibition of Neuronal Na+ Channels by Antidepressant Drugs
Pancrazio, J. J., Kamatchi, G. L., Roscoe, A. K., & Lynch, C. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37206-4 · Cited by 311
Electrophysiologic Analysis of a Chronic Seizure Model After Unilateral Hippocampal KA Injection
Bragin, A., Engel, J., Wilson, C. L., Vizentin, E., & Mathern, G. W. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00849.x · Cited by 307
Gustafson, E. L., Durkin, M. M., Bard, J. A., Zgombick, J., & Branchek, T. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15241.x · Cited by 295
McCormick, D. A., & Wang, Z. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018791 · Cited by 285
Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis
Dubé, C., Richichi, C., Bender, R. A., Chung, G., Litt, B., & Baram, T. Z. (2006) · Brain · doi:10.1093/brain/awl018 · Cited by 283
Experimental Models of Epilepsy: A Manual for the Laboratory Worker.
Wasterlain, C. (1973) · Archives of Neurology · doi:10.1001/archneur.1973.00490220092020 · Cited by 265
Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats
Coenen, A. M. L., Drinkenburg, W. H. I. M., Inoue, M., & van Luijtelaar, E. L. J. M. (1992) · Epilepsy Research · doi:10.1016/0920-1211(92)90029-s · Cited by 258
Chugani, D. C., Chugani, H. T., Muzik, O., Shah, J. R., Shah, A. K., Canady, A., Mangner, T. J., & Chakraborty, P. K. (1998) · Annals of Neurology · doi:10.1002/ana.410440603 · Cited by 255
PET imaging of 5-HT1Areceptor binding in patients with temporal lobe epilepsy
Toczek, M. T., Carson, R. E., Lang, L., Ma, Y., Spanaki, M. V., Der, M. G., Fazilat, S., Kopylev, L., Herscovitch, P., Eckelman, W. C., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000049930.93113.20 · Cited by 241
Characterization and distribution of putative 5‐ht7receptors in guinea‐pig brain
To, Z. P., Bonhaus, D. W., Eglen, R. M., & Jakeman, L. B. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16327.x · Cited by 225
5-HT 7 receptors: current knowledge and future prospects
Vanhoenacker, P., Haegeman, G., & Leysen, J. E. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01432-7 · Cited by 209
A Noradrenergic and Serotonergic Hypothesis of the Linkage Between Epilepsy and Affective Disorders
Jobe, P. C., Dailey, J. W., & Wernicke, J. F. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i4.10 · Cited by 193
Limbic reductions of 5-HT 1A receptor binding in human temporal lobe epilepsy
Savic, I., Lindström, P., Gulyás, B., Halldin, C., Andrée, B., & Farde, L. (2004) · Neurology · doi:10.1212/01.wnl.0000123696.98166.af · Cited by 183
D'Ambrosio, R. (2004) · Brain · doi:10.1093/brain/awh337 · Cited by 176
Analysis of extracellular firing patterns of deep temporal lobe structures in man
Babb, T. L., Carr, E., & Crandall, P. H. (1973) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(73)90252-6 · Cited by 174
5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study
Merlet, I. (2004) · Brain · doi:10.1093/brain/awh109 · Cited by 173
Neurotransmitter Actions in the Thalamus and Cerebral Cortex
McCormick, D. A. (1992) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199204010-00004 · Cited by 166
Sound-induced seizures in serotonin 5-HT2c receptor mutant mice
Brennan, T. J., Seeley, W. W., Kilgard, M., Schreiner, C. E., & Tecott, L. H. (1997) · Nature Genetics · doi:10.1038/ng0897-387 · Cited by 164
Löscher, W., Annies, R., & Hönack, D. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90258-u · Cited by 150
Electric activity in the neocortex of freely moving young and aged rats
Buzsáki, G., Bickford, R. G., Armstrong, D. M., Ponomareff, G., Chen, K. S., Ruiz, R., Thal, L. J., & Gage, F. H. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90095-4 · Cited by 149
Clinckers, R., Smolders, I. J., Meurs, A., Ebinger, G., & Michotte, Y. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02355.x · Cited by 138
Sheldon, P. W., & Aghajanian, G. K. (1991) · Synapse · doi:10.1002/syn.890090307 · Cited by 131
Anticonvulsant Effect of Fluoxetine on Focally Evoked Limbic Motor Seizures in Rats
Prendiville, S., & Gale, K. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02425.x · Cited by 130
Dailey, J. W., Yan, Q.-S., Mishra, P. K., Burger, R. L., & Jobe, P. C. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11327-x · Cited by 128
Pharmacology of absence epilepsy
Manning, J.-P. A., Richards, D. A., & Bowery, N. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.08.006 · Cited by 127
Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells
Deák, F., Lasztóczi, B., Pacher, P., Petheö, G. L., Kecskeméti, V., & Spät, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00206-3 · Cited by 124
Halász, P., Terzano, M. G., & Parrino, L. (2002) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(01)00290-8 · Cited by 121
REVIEW ARTICLE Acute and Chronic Electrical Stimulation of the Centromedian Thalamic Nucleus
Velasco, M., Velasco, F., Velasco, A. L., Jiménez, F., Brito, F., & Márquez, I. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(00)00085-0 · Cited by 113
The role of mammalian ionotropic receptors in synaptic plasticity: LTP, LTD and epilepsy
Kullmann, D. M., Asztély, F., & Walker, M. C. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000640 · Cited by 108
Global Increases in Seizure Susceptibility in Mice Lacking 5-HT2CReceptors: A Behavioral Analysis
Applegate, C. D., & Tecott, L. H. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6901 · Cited by 106
Ahmad, S., Fowler, L. J., & Whitton, P. S. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.02.002 · Cited by 100
Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat
Jobe, P. C., Picchioni, A. L., & Chin, L. (1973) · Life Sciences · doi:10.1016/0024-3205(73)90271-3 · Cited by 97
Leander, J. D. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb01712.x · Cited by 96
Giaretta, D., Avoli, M., & GLOOR, P. (1987) · Brain Research · doi:10.1016/0006-8993(87)90990-5 · Cited by 94
Parsons, L. H., Kerr, T. M., & Tecott, L. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00254.x · Cited by 93
Effects of Fluoxetine and TFMPP on Spontaneous Seizures in Rats with Pilocarpine‐induced Epilepsy
Hernandez, E. J., Williams, P. A., & Dudek, F. E. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.48701.x · Cited by 93
Serotonin and Hippocampal Neurogenesis
Gould, E. (1999) · Neuropsychopharmacology · doi:10.1038/sj.npp.1395369 · Cited by 92
Gráf, M., Jakus, R., Kántor, S., Lévay, G. I., & Bagdy, G. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.072 · Cited by 89
Self-citationChapin, E. M., & Andrade, R. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29552-5 · Cited by 86
Mechanism of Fluoxetine Block of Cloned Voltage-Activated Potassium Channel Kv1.3
Choi, J., Hahn, S. J., Rhie, D., Yoon, S. H., Jo, Y., & Kim, M.-S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35063-3 · Cited by 85
Does Serotonin Play a Role in Epilepsy?
Theodore, W. H. (2003) · Epiliepsy currents/Epilepsy currents · doi:10.1046/j.1535-7597.2003.03508.x · Cited by 80
Cellular Mechanisms in Experimental Epileptic Seizures
Matsumoto, H., & Marsan, C. A. (1964) · Science · doi:10.1126/science.144.3615.193 · Cited by 80
Effect of fluoxetine on a neuronal, voltage‐dependent potassium channel (Kv1.1)
Tytgat, J., Maertens, C., & Daenens, P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701545 · Cited by 79
Trottier, S., Evrard, B., Vignal, J., Scarabin, J., & Chauvel, P. (1996) · Epilepsy Research · doi:10.1016/0920-1211(96)00033-2 · Cited by 78
Francis, P. T., Pangalos, M. N., Pearson, R. C. A., Middlemiss, D. N., Stratmann, G. C., & Bowen, D. M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11149-x · Cited by 78
Dailey, J. W., Reith, M. E. A., Yan, Q., Li, M.-Y., & Jobe, P. C. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00288-7 · Cited by 74
Löscher, W. (1984) · PubMed · Cited by 74
Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats
Yan, Q., Jobe, P. C., Cheong, J.-H., Ko, K.-H., & Dailey, J. W. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00241089 · Cited by 73
α-[ 11 C] methyl- L -tryptophan and glucose metabolism in patients with temporal lobe epilepsy
Natsume, J., Kumakura, Y., Bernasconi, N., Soucy, J., Nakai, A., Rosa‐Neto, P., Fedi, M., Dubeau, F., Andermann, F., Lisbona, R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000052682.99812.f5 · Cited by 72
Serotonergic 5-HT2C Receptors as a Potential Therapeutic Target for the Design Antiepileptic Drugs
Isaac, M. B. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053386980 · Cited by 70
Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats
Wada, Y., Shiraishi, J., Nakamura, M., et al. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01322-4 · Cited by 67
Jakus, R., Gráf, M., Juhász, G., Gerber, K., Lévay, G. I., Halász, P., & Bagdy, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00352-2 · Cited by 63
Self-citationEffect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats
Statnick, M. A., Maring-Smith, M., Clough, R. W., Wang, C., Dailey, J. W., Jobe, P. C., & Browning, R. A. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00519-x · Cited by 62
GLOOR, P. (1978) · PubMed · Cited by 62
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin
Pasini, A., Tortorella, A. A. V., & Gale, K. (1996) · Brain Research · doi:10.1016/0006-8993(96)00291-0 · Cited by 61
Filakovszky, J., Gerber, K., & Bagdy, G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00015-4 · Cited by 60
Self-citationChapin, E. M., & Andrade, R. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29551-3 · Cited by 60
Wada, Y., Nakamura, M., Hasegawa, H., et al. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90828-9 · Cited by 59
Theodore, W. H., Giovacchini, G., Bonwetsch, R., Bagic, A. I., Reeves‐Tyer, P., Herscovitch, P., & Carson, R. E. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00458.x · Cited by 59
Gariboldi, M., Tutka, P., SAMANIN, R., & Vezzani, A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15745.x · Cited by 57
Clinckers, R., Smolders, I. J., Meurs, A., Ebinger, G., & Michotte, Y. M. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.032 · Cited by 56
Anticonvulsant effect of intranigral fluoxetine
Pasini, A., Tortorella, A. A. V., & Gale, K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91320-e · Cited by 56
Browning, R. A., Hoffmann, W. E., & Simonton, R. L. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb31540.x · Cited by 55
Wada, Y., Shiraishi, J., Nakamura, M., & Hasegawa, H. (1995) · Psychopharmacology · doi:10.1007/bf02245959 · Cited by 55
Bourson, A., Kapps, V., Zwingelstein, C., Rudler, A., Boess, F., & Sleight, A. J. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005123 · Cited by 53
Neuropharmacology of Progressive Myoclonus Epilepsy: Response to 5‐Hydroxy‐L‐Tryptophan
Pranzatelli, M. R., Tate, E., Huang, Y., Haas, R., Bodensteiner, J. B., Ashwal, S., & Franz, D. N. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01615.x · Cited by 53
The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity.
Welsh, J. P., Placantonakis, D. G., Warsetsky, S. I., Marquez, R. G., Bernstein, L. I., & Aicher, S. A. (2002) · PubMed · Cited by 52
Derry, C. P., Benjamin, C. F. A., Bladin, P. F., Bars, D. L., Tochon‐Danguy, H., Berkovic, S. F., Zimmer, L., Costes, N., Mulligan, R. S., & Reutens, D. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.09.052 · Cited by 52
Borowicz, K. K., Stępień, K. M., & Czuczwar, S. J. (2006) · PubMed · Cited by 49
Stimulation of 5-HT1A receptors increases the seizure threshold for picrotoxin in mice
Peričić, D., Lazić, J., Jembrek, M. J., & Štrac, D. Š. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.021 · Cited by 40
Watanabe, K., Ashby, C. R., Katsumori, H., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00258-2 · Cited by 40
Modulation of rat neocortical high-voltage spindle activity by receptor subtype specific drugs
Jäkälä, P., Sirviö, J., Koivisto, E., Björklund, M., Kaukua, J., & Riekkinen, P. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00272-m · Cited by 39
Jakus, R., Gráf, M., Andó, R. D., Balogh, B., Gacsályi, I., Lévay, G. I., Kántor, S., & Bagdy, G. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.087 · Cited by 37
Self-citationNorfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies
Kecskeméti, V., Rusznák, Z., Riba, P., Pál, B. Z., Wagner, R. J., Harasztosi, C., Nánási, P. P., & Szűcs, G. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.06.027 · Cited by 35
Self-citationDevelopment and Adult Plasticity of Serotoninergic Neurons and Their Target Cells
Azmitia, E. C., & Whitaker‐Azmitia, P. M. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60921-3_1 · Cited by 31
8-OH-DPAT and MK-801 affect epileptic activity independently of vigilance
Filakovszky, J., Kántor, S., Halász, P., & Bagdy, G. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00120-0 · Cited by 31
Self-citationChapter 40 Models of focal epilepsy
Engel, J. (2004) · Supplements to Clinical neurophysiology · doi:10.1016/s1567-424x(09)70376-9 · Cited by 16
Hagan, J. J., Hatcher, J. P., & Slade, P. D. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00627-3 · Cited by 15
Sleep disruption with basal forebrain lesions decreases latency to amygdala kindling in cats
Shouse, M. N., Sterman, M. B., Hauri, P., & Belsito, O. (1984) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(84)90063-4 · Cited by 14
Chapter 43 Models for generalized seizures
Holmes, G. L. (2004) · Supplements to Clinical neurophysiology · doi:10.1016/s1567-424x(09)70379-4 · Cited by 12
Cited by
Mechanisms of sudden unexpected death in epilepsy: the pathway to prevention
Massey, C. A., Sowers, L. P., Dlouhy, B. J., & Richerson, G. B. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.64 · Cited by 331
Applications for α-lactalbumin in human nutrition
Layman, D. K., Lönnerdal, B., & Fernstrom, J. D. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy004 · Cited by 316
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
The role of dopamine signaling in epileptogenesis
Bozzi, Y., & Borrelli, E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00157 · Cited by 199
Dead in the Night: Sleep-Wake and Time-Of-Day Influences on Sudden Unexpected Death in Epilepsy
Purnell, B. S., Thijs, R. D., & Buchanan, G. F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01079 · Cited by 67
Metadata
- Authors
- Bagdy, G., Kecskemeti, V., Riba, P., & Jakus, R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-10-24
- Volume
- 100
- Issue
- 4
- Pages
- 857-873
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2017061363
- Cited by
- 367
- References
- 102
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.